Bank OZK’s Quest Diagnostics DGX Stock Holding History

Bank OZK’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.86M	Buy	14,572 +214	+1%	+$41.6K	1.01%	35
2025 Q4	$2.49M	Sell	14,358 -73	-0.5%	-$13.3K	0.88%	37
2025 Q3	$2.75M	Buy	14,431 +629	+5%	+$112K	0.97%	32
2025 Q2	$2.48M	Buy	13,802 +1,571	+13%	+$273K	0.95%	34
2025 Q1	$2.07M	Buy	+12,231	New	+$2.01M	0.86%	40

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Bank OZK's DGX Position: Q1 2026 in Review

Bank OZK increased its Quest Diagnostics (DGX) stake by 1.5% in Q1 2026, buying an estimated $41.6K and bringing the position to 14,572 shares worth $2.86M. The position accounts for 1.01% of the portfolio, ranked #35.

Bank OZK first reported a position in DGX in Q1 2025 and has held it in 5 quarters since. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Bank OZK held 14,572 shares of Quest Diagnostics worth $2.86M as of Q1 2026.
Bank OZK bought 214 Quest Diagnostics shares in Q1 2026, an estimated $41.6K.
Quest Diagnostics made up 1.01% of Bank OZK's portfolio in Q1 2026, its #35 holding.
Bank OZK first reported a position in Quest Diagnostics in Q1 2025 and has held it in 5 quarters since.
1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Bank OZK's 13F filing for Q1 2026, filed 13 May 2026.